Olmis™-A

Therapeutic Segment:
Anti-hypertensive

Generic Name:
Amlodipine/Olmesartan Medoxomil

Description:
The Amlodipine Besilate and Olmesartan Medoxomil are components of Olmis-A.

Indication:
Olmis-A is a dihydropyridine calcium channel blocker and angiotensin II receptor blocker combination product indicated for the treatment of hypertension, alone or with other antihypertensive agents, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. Olmis-A is indicated as initial therapy in patients likely to need multip le antihypertensive agents to achieve their blood pressure goals.

Formulation:

• Tablets

Strength:

• 10mg/40mg
• 10mg/20mg
• 5mg/40mg
• 5mg/20mg

Pack Size:

• 20’s